Our investigation of systemic and local changes of the expression of checkpoint inhibitor molecules PD-1, CTLA-4, CD160, and 2B4 revealed significant upregulation of all tested markers especially in the bone marrow, suggesting that the immunosuppressive tumor microenvironment fuels immune escape in multiple myeloma. This evidence concerns the gene CTLA4 and AL amyloidosis.